Dennis Podlesak

Insider Reports History

Location
Alameda, CA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis Podlesak:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 239,763 $5,037,420 $21.01 04 Feb 2026 Direct
Syndax Pharmaceuticals Inc Director Stock Options (Right to buy) 0 18 Aug 2025 Direct

Insider Reports Filed by Dennis Podlesak

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 04 Feb 2026 1 $0 4 Director 06 Feb 2026, 16:14
SNDX Syndax Pharmaceuticals Inc 14 Aug 2025 10 -$460,380 4 Director 18 Aug 2025, 17:02
SNDX Syndax Pharmaceuticals Inc 05 Feb 2025 1 $0 4 Director 07 Feb 2025, 16:41
SNDX Syndax Pharmaceuticals Inc 07 Feb 2024 1 $0 4 Director 09 Feb 2024, 16:04
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 $0 4 Director 03 Feb 2023, 15:57
SNDX Syndax Pharmaceuticals Inc 15 Sep 2022 9 -$1,399,680 4 Director 16 Sep 2022, 17:34
SNDX Syndax Pharmaceuticals Inc 02 Feb 2022 1 $0 4 Director 03 Feb 2022, 16:30
SNDX Syndax Pharmaceuticals Inc 05 Oct 2021 1 $0 4 Director 06 Oct 2021, 16:09